Judge Orders FDA To Approve Watson's Generic Actos

Law360, New York (October 22, 2012, 4:42 PM EDT) -- A Washington federal judge on Monday ordered the U.S. Food and Drug Administration to immediately approve Watson Laboratories Inc.'s generic version of Takeda North America Inc. diabetes drug Actos, after Watson accused the FDA of attempting to rob it of a 180-day marketing exclusivity period.

In a one-page order, U.S. District Judge Amy Berman Jackson granted Watson's summary judgment motion and ordered the FDA to immediately approve the generics maker's abbreviated new drug application for generic Actos, “so that Watson Laboratories may participate in what remains...
To view the full article, register now.